Geviti announced the launch of clinical-grade genetics integrated with Makor AI, combining DNA, biomarkers, and AI to deliver personalized preventative care. The update is product-focused with no reported financial metrics, suggesting limited near-term market impact.
Geviti announced the launch of clinical-grade genetics integrated with Makor AI, combining DNA, biomarkers, and AI to deliver personalized preventative care. The update is product-focused with no reported financial metrics, suggesting limited near-term market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.18
